|
75
|
273
|
5j8cA |
Human mof c316s, e350q crystal structure |
|
41
|
117
|
5j0dA |
Crystal structure of the bromodomain of human crebbp in complex with a benzoxazepine compound |
|
56
|
234
|
5i8gA |
Cbp in complex with cpd637 ((r)-4-methyl-6-(1-methyl-3-(1-methyl-1h-pyrazol-4-yl)-1h-indazol-5-yl)-1,3,4,5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one) |
|
54
|
139
|
5i29A |
Taf1(2) bound to a pyrrolopyridone compound |
|
62
|
234
|
5i8bA |
Cbp in complex with cpd23 ((r)-6-(3-(benzyloxy)phenyl)-4-methyl-1,3,4,5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one) |
|
41
|
115
|
5i86A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02778174 |
|
40
|
114
|
5i83A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02773986 |
|
56
|
135
|
5i1qA |
Second bromodomain of taf1 bound to a pyrrolopyridone compound |
|
38
|
122
|
5hp0A |
Solution structure of taz2-p53ad2 |
|
48
|
158
|
5hpdA |
Solution structure of taz2-p53tad |
|
49
|
171
|
5houA |
Solution structure of p53tad-taz1 |
|
0
|
15
|
5h43C |
Structural and mechanistical studies of the nuclear import by importin-alpha |
|
1
|
10
|
5h43B |
Structural and mechanistical studies of the nuclear import by importin-alpha |
|
42
|
109
|
5fe7A |
Crystal structure of human pcaf bromodomain in complex with fragment zb2216 (fragment 11) |
|
40
|
108
|
5fe5A |
Crystal structure of human pcaf bromodomain in complex with fragment mb093 (fragment 7) |
|
39
|
108
|
5fe8A |
Crystal structure of human pcaf bromodomain in complex with compound sl1126 (compound 12) |
|
41
|
109
|
5fe9A |
Crystal structure of human pcaf bromodomain in complex with compound sl1122 (compound 13) |
|
39
|
107
|
5fe2A |
Crystal structure of human pcaf bromodomain in complex with fragment br013 (fragment 3) |
|
44
|
118
|
6frfA |
Crystal structure of crebbp bromodomain complexd with pa10 |
|
39
|
114
|
6fr0A |
Crystal structure of crebbp bromodomain complexd with pb08 |
|
2
|
9
|
6fo9B |
Vitamin d nuclear receptor complex 2 |
|
40
|
116
|
6fquA |
Crystal structure of crebbp bromodomain complexd with dr09 |
|
2
|
9
|
6fobB |
Vitamin d receptor complex 5 |
|
38
|
115
|
6fqoA |
Crystal structure of crebbp bromodomain complexd with dt29 |
|
2
|
9
|
6fo7B |
Vitamin d nuclear receptor complex 3 |
|
2
|
9
|
6fo8B |
Vitamin d nuclear receptor complex 4 |
|
2
|
10
|
6fodB |
Vitamin d nuclear receptor complex 1 |
|
30
|
130
|
6fgsA |
Solution structure of p300taz2-p73ta1 |
|
29
|
124
|
6fgnA |
Solution structure of p300taz2-p63ta |
|
93
|
245
|
6ficT |
Bivalent inhibitor unc4512 bound to the taf1 bromodomain tandem |
|
11
|
53
|
6ds6A |
Crystal structure of p300 zz domain in complex with histone h3 peptide |
|
34
|
87
|
6dnqB |
Hbz77 in complex with kix and c-myb |
|
36
|
84
|
6dmxB |
Hbz56 in complex with kix and c-myb |
|
50
|
218
|
6cw3F |
Crystal structure of a yeast saga transcriptional coactivator ada2/gcn5 hat subcomplex, crystal form 2 |
|
62
|
241
|
6cw2D |
Crystal structure of a yeast saga transcriptional coactivator ada2/gcn5 hat subcomplex, crystal form 1 |
|
80
|
274
|
6ct2A |
Myst histone acetyltransferase kat6a/b in complex with wm-1119 |
|
107
|
318
|
6bnsA |
Structure of human pregnane x receptor ligand binding domain bound tethered with src co-activator peptide and compound 25a aka bicyclic hexafluoroisopropyl 2 alcohol sulfonamides |
|
81
|
272
|
6ba4A |
Crystal structure of myst acetyltransferase domain in complex with acetyl-coa cofactor |
|
75
|
272
|
6ba2A |
Crystal structure of myst acetyltransferase domain in complex with inhibitor |
|
39
|
115
|
6ay5A |
Crebbp bromodomain in complex with cpd17 (5-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-3-methylbenzo[d]thiazol-2(3h)-one) |
|
41
|
115
|
6ay3A |
Crebbp bromodomain in complex with cpd16 (5-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1h-indole-3-carboxamide) |
|
40
|
112
|
6axqA |
Crebbp bromodomain in complex with cpd6 (methyl 1h-indole-3-carboxylate) |
|
39
|
114
|
6alcA |
Crebbp bromodomain in complex with cpd 4 (1-(1-(cyclopropylmethyl)-3-(1h-indol-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
2
|
8
|
5yp6B |
Rorgamma (263-509) complexed with src2 and compound 6 |
|
33
|
125
|
5y7wA |
Crystal structure of the nco-a1 pas-b domain with yl-2 |
|
3
|
11
|
5ycpB |
Human ppargamma ligand binding domain complexed with rosiglitazone |
|
38
|
117
|
5xxhA |
Crystal structure analysis of the cbp |
|
39
|
114
|
5w0lA |
Crebbp bromodomain in complex with cpd10 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
67
|
209
|
5wh1A |
Apo form of the c-terminal region of human transcription factor iib |
|
168
|
621
|
5u7gA |
Crystal structure of the catalytic core of cbp |
